Vanguard Fiduciary Trust’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Vanguard Fiduciary Trust’s Portfolio SGMO Stock Details SGMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-2,310,297	Closed	-$571K	–	4141
2026 Q1	$571K	Buy	+2,310,297	New	+$919K	﹤0.01%	3172

Other funds holding SGMO

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return

AIM

Axiom Investment Management New York $150M AUM

FTUS

Flow Traders U.S. New York $2.43B AUM 44.44% 1-Year Est. Return

HIG

Heritage Investment Group Pompano Beach, Florida $744M AUM 20.51% 1-Year Est. Return

Vanguard Fiduciary Trust's SGMO Position: Q2 2026 in Review

Vanguard Fiduciary Trust sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2026, closing a stake of 2,310,297 shares — an estimated $571K sold.

Vanguard Fiduciary Trust first reported a position in SGMO in Q1 2026 and held it in 1 quarter. The position peaked at $571K in Q1 2026. 6 funds tracked by Wall St. Rank hold SGMO as of Q2 2026.

Vanguard Fiduciary Trust reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2026 after selling out during the quarter.
Vanguard Fiduciary Trust sold 2,310,297 SANGAMO THERAPEUTICS INC shares in Q2 2026, an estimated $571K.
Vanguard Fiduciary Trust first reported a position in SANGAMO THERAPEUTICS INC in Q1 2026 and held it in 1 quarter.
Vanguard Fiduciary Trust's SANGAMO THERAPEUTICS INC position peaked at $571K in Q1 2026.
6 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.